122 related articles for article (PubMed ID: 10776885)
1. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.
Goldsmith SJ; Kostakoglu L
Semin Ultrasound CT MR; 2000 Apr; 21(2):129-38. PubMed ID: 10776885
[TBL] [Abstract][Full Text] [Related]
2. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
Blum J; Handmaker H; Lister-James J; Rinne N
Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
[TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine imaging of lung cancer.
Goldsmith SJ; Kostakoglu L
Radiol Clin North Am; 2000 May; 38(3):511-24. PubMed ID: 10855258
[TBL] [Abstract][Full Text] [Related]
4. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Naalsund A; Maublant J
Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.
Grewal RK; Dadparvar S; Yu JQ; Babaria CJ; Cavanaugh T; Sherman M; Jacobstein J
Cancer J; 2002; 8(5):400-4. PubMed ID: 12416898
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
7. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules.
Blum JE; Handmaker H; Rinne NA
Chest; 1999 Jan; 115(1):224-32. PubMed ID: 9925088
[TBL] [Abstract][Full Text] [Related]
8. The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals.
Wu Q; Zhong L; Xie X
Clin Transl Oncol; 2021 Feb; 23(2):296-310. PubMed ID: 32548796
[TBL] [Abstract][Full Text] [Related]
9. Limited value of ⁹⁹mTc depreotide single photon emission CT compared with CT for the evaluation of pulmonary lesions.
Harders SW; Madsen HH; Hjorthaug K; Rehling M; Rasmussen TR; Pedersen U; Pilegaard HK; Meldgaard P; Baandrup UT; Rasmussen F
Br J Radiol; 2012 Jul; 85(1015):e307-13. PubMed ID: 22745210
[TBL] [Abstract][Full Text] [Related]
10. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
Cronin P; Dwamena BA; Kelly AM; Carlos RC
Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
[TBL] [Abstract][Full Text] [Related]
11. [Lung scintigraphy with technetium 99m depreotide in the assessment of solitary pulmonary nodules].
Rebollo AC; Jiménez-Hoyuela JM; Martínez del Valle MD; Fernández Aguirre C; Soria C; Velasco JL
Arch Bronconeumol; 2004 Nov; 40(11):534-6. PubMed ID: 15530345
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
13. False-positive technetium 99m depreotide scintigraphy resulting from round atelectasis.
Thomas LP; Balingit AG; Morison DS; Gilman MD
J Thorac Imaging; 2003 Apr; 18(2):97-9. PubMed ID: 12700484
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
Menda Y; Kahn D
Semin Nucl Med; 2002 Apr; 32(2):92-6. PubMed ID: 11965604
[TBL] [Abstract][Full Text] [Related]
15. [Fusion of pulmonary scintigraphy with Tc99m-depreotide imaging with CT scan in recognizing solitary pulmonary nodule].
Szaluś N; Chciałowski A; From S; Zagrodzka M; Pietrzykowski J; Dziuk E
Pol Merkur Lekarski; 2008 Oct; 25(148):330-4. PubMed ID: 19145931
[TBL] [Abstract][Full Text] [Related]
16. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic efficacy of 99Tcm-MIBI SPECT/CT and 18F-FDG coincidence SPECT/CT for solitary pulmonary nodules: a comparative study].
Jia X; Xue JJ; Gao R; Deng HX; Zhang FR; Yang AM
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):386-90. PubMed ID: 27063168
[TBL] [Abstract][Full Text] [Related]
19. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
[TBL] [Abstract][Full Text] [Related]
20. [Technetium99 labelled synthetic somatostatin analogue (depreotide) in the diagnosis of peripheral solitary pulmonary nodules].
Chciałowski A; Dziuk E; From S; Płusa T; Lubiński W; Pietrzykowski J; Zabicka M; Hussain N
Pol Arch Med Wewn; 2004 Sep; 112(3):1031-8. PubMed ID: 15727084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
